The Centers for Disease Control and Prevention (CDC) is reviewing the death of a woman that occurred after she received the Johnson & Johnson’s COVID-19 vaccine.

The Oregon Health Authority said in a statement on Thursday that it was informed that the CDC is investigating the death of a woman in her late 50s, who received the vaccine before the state ordered the pause on its use.

Two weeks after getting the vaccine, the woman developed a rare but serious blood clot that was seen with very low platelets.

ADVERTISEMENT

“Until the investigation is complete, it cannot be concluded whether her death is related to the vaccine,” the OHA said.

The agency said it was notified about the death on April 20, two days after the CDC was notified on April 18.

Click Here: St George illawarra Dragons Jersey

The investigation comes roughly a week after the CDC and Food and Drug Administration recommended a nationwide pause on the vaccine due to reports of six rare blood clots following vaccination.

A CDC advisory panel met on April 14 but postponed making a recommendation because they wanted to gather more evidence about the risk of rare blood clots and its possible link to the vaccine.  The panel is expected to meet again on Friday.

Meanwhile in Texas, the CDC and FDA are investigating after another woman was hospitalized following receiving the vaccine.

The Department of State Health Services told local ABC affiliate KUVE on Thursday that it was notified “about a possible case in Texas.” However, the agency didn’t provide details about the case to protect the patient’s privacy.

ADVERTISEMENT

“The patient is an adult female who was hospitalized after receiving the J&J vaccine with symptoms that appear to be consistent with those few other reported cases,” the agency said.

Both the OHA and Texas DSHS asked vaccine providers to immediately stop providing the vaccine after federal regulators recommended doing so. 

The Hill has reached out to DSHS and Johnson & Johnson for comment.